Prostatic Neoplasms  >>  prednisone delayed-release tablet  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
prednisone delayed-release tablet / Generic mfg.
NCT01120470: OGX-427 in Castration Resistant Prostate Cancer Patients

Completed
2
74
Canada, US
OGX-427, Apatorsen, Prednisone, Rayos, Sterapred
British Columbia Cancer Agency, Achieve Life Sciences
Castration Resistant Prostate Cancer
10/12
06/14
NCT01848067: Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Completed
1/2
9
US
Alisertib, MLN8237, Abiraterone acetate, Abiraterone, Zytiga, Prednisone, Cortan, Deltasone, Orasone, Prednisone Intensol, Sterapred, Rayos
Sidney Kimmel Cancer Center at Thomas Jefferson University, Millennium: The Takeda Oncology Company
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
03/15
06/16

Download Options